Global Image Guided Radiotherapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Types;
Soft-Tissue Imaging, Lung MRI, Simplifying Cardiac MRI, Simplifying MRI-Conditional Implant Scans, Silent MRI Scanning and Others.By End Use;
Hospitals, Smart Cancer Centers, Research Institutes and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Image Guided Radiotherapy Market (USD Million), 2021 - 2031
In the year 2024, the Global Image Guided Radiotherapy Market was valued at USD 2,089.37 million. The size of this market is expected to increase to USD 2,959.60 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.1%.
The global image-guided radiotherapy (IGRT) market is witnessing substantial growth attributed to several key factors. IGRT, a sophisticated radiation therapy technique that utilizes imaging technology to precisely target tumors while minimizing damage to surrounding healthy tissues, is becoming increasingly prevalent in cancer treatment. With cancer incidence rates on the rise globally, there is a growing demand for advanced radiotherapy solutions that offer improved accuracy and efficacy. IGRT meets this demand by providing real-time imaging guidance during treatment sessions, allowing healthcare providers to adapt treatment plans based on the patient's anatomy and tumor position, thereby enhancing treatment outcomes and minimizing side effects.
Furthermore, technological advancements in imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), are driving innovation in the IGRT market. Integration of these imaging technologies with radiotherapy systems enables precise visualization of tumors and surrounding anatomy, facilitating highly targeted radiation delivery. Additionally, developments in image registration and motion tracking software enhance the accuracy of tumor localization and facilitate real-time monitoring of organ motion during treatment, further improving treatment precision and patient safety.
Despite the significant growth opportunities, the IGRT market faces challenges such as high initial investment costs and limited accessibility in certain regions. The implementation of IGRT requires specialized equipment, infrastructure, and trained personnel, which may pose barriers to adoption, particularly in resource-constrained healthcare settings. However, as awareness about the benefits of IGRT continues to grow among healthcare providers and patients, coupled with ongoing advancements in technology and increasing investments in healthcare infrastructure, the global IGRT market is poised for continued expansion in the foreseeable future.
Global Image Guided Radiotherapy Market Recent Developments
- In 2023, Philips extended the company’s mobile C-arm portfolio with Zenition 10.
- In 2023, GE HealthCare Advances PET/MR Capabilities with AIR Technologies to enhance diagnostic precision and simplify treatment evaluation while elevating patient comfort.
Segment Analysis
This report extensively covers different segments of Global Image Guided Radiotherapy Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
The global image-guided radiotherapy (IGRT) market has been segmented by types, end use, and geography to cater to diverse needs and preferences within the industry. In terms of types, IGRT systems are categorized based on the imaging modalities used, such as cone-beam computed tomography (CBCT), magnetic resonance imaging (MRI), and positron emission tomography (PET), among others. Each modality offers unique advantages in terms of imaging resolution, soft tissue visualization, and real-time monitoring capabilities, allowing healthcare providers to tailor treatment plans according to patient-specific requirements.
Furthermore, the end-use segmentation of the IGRT market encompasses various healthcare settings where radiotherapy procedures are performed, including hospitals, cancer treatment centers, and research institutions. Each end-use segment presents distinct opportunities and challenges in terms of equipment requirements, patient volumes, and budget considerations. Hospitals, for instance, account for a significant share of the IGRT market due to the high volume of cancer patients they serve and the availability of comprehensive treatment facilities.
Geographically, the IGRT market is segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region exhibits unique market dynamics influenced by factors such as healthcare infrastructure, regulatory landscape, reimbursement policies, and prevalence of cancer. North America and Europe dominate the global IGRT market owing to well-established healthcare systems, high adoption rates of advanced medical technologies, and significant investments in cancer research and treatment. However, the Asia Pacific region is witnessing rapid growth driven by increasing cancer incidence rates, improving healthcare infrastructure, and rising awareness about the benefits of IGRT among patients and healthcare providers.
Global Image Guided Radiotherapy Segment Analysis
In this report, the global image guided radiotherapy market has been segmented by types, end use and geography.
Global Image Guided Radiotherapy Market, Segmentation by Types
The Global Image Guided Radiotherapy Market has been segmented by Types into Soft-Tissue Imaging, Lung MRI, Simplifying Cardiac MRI, Simplifying MRI-Conditional Implant Scans, Silent MRI Scanning and Others.
The segmentation of the global image-guided radiotherapy (IGRT) market into various types reflects the diverse applications and advancements in imaging technologies within radiotherapy. Soft-tissue imaging holds a prominent segment, as it allows for precise visualization of tumors and surrounding structures, enabling accurate treatment planning and delivery. Lung MRI is another important segment, particularly for thoracic cancers, as it provides detailed imaging of lung tumors and nearby critical structures, facilitating targeted radiation therapy while minimizing damage to healthy tissue.
In addition, the market includes segments such as simplifying cardiac MRI and MRI-conditional implant scans, which cater to specific patient populations and clinical needs. Simplifying cardiac MRI techniques enable clear visualization of the heart and surrounding vasculature, aiding in the treatment of cardiac tumors and other conditions. Similarly, MRI-conditional implant scans ensure safe and accurate imaging for patients with implanted devices, such as pacemakers or cochlear implants, allowing for comprehensive treatment planning without compromising patient safety.
Furthermore, innovations such as silent MRI scanning address patient comfort and accessibility, offering a quieter imaging experience that reduces anxiety and improves overall patient satisfaction. Other segments encompass emerging technologies and applications within IGRT, highlighting the continuous evolution and diversification of imaging-guided radiotherapy techniques. As advancements in imaging modalities and treatment planning software continue to progress, the segmentation of the IGRT market provides insights into the tailored solutions available for various clinical scenarios, ultimately improving patient outcomes and quality of care.
Global Image Guided Radiotherapy Market, Segmentation by End Use
The Global Image Guided Radiotherapy Market has been segmented by End Use into Hospitals, Smart Cancer Centers, Research Institutes and Others.
The segmentation of the global image-guided radiotherapy (IGRT) market by end-use reflects the diverse range of healthcare facilities and organizations that utilize this advanced radiotherapy technique. Hospitals constitute a significant segment, representing the primary setting for cancer treatment worldwide. With the increasing prevalence of cancer and the growing demand for precise and effective treatment options, hospitals are at the forefront of adopting IGRT technology to enhance patient care. The integration of IGRT systems into hospital oncology departments allows for comprehensive cancer treatment, offering patients access to state-of-the-art radiation therapy with real-time imaging guidance.
Smart cancer centers represent an emerging segment within the IGRT market, characterized by facilities equipped with advanced technologies and innovative treatment approaches. These centers leverage cutting-edge IGRT systems alongside other smart technologies, such as artificial intelligence (AI) and data analytics, to optimize treatment planning, delivery, and monitoring. By combining IGRT with intelligent automation and personalized treatment algorithms, smart cancer centers aim to improve treatment outcomes, reduce treatment times, and enhance the overall patient experience.
Research institutes play a crucial role in driving innovation and advancement in the field of image-guided radiotherapy. These institutes contribute to the development of new IGRT technologies, imaging modalities, treatment protocols, and clinical guidelines through research, clinical trials, and collaborative partnerships. By conducting translational research and clinical studies, research institutes generate valuable insights into the efficacy and safety of IGRT, paving the way for continuous improvement and refinement of this advanced radiotherapy technique. Additionally, research institutes serve as training hubs for healthcare professionals, providing education and certification programs to ensure the widespread adoption and effective utilization of IGRT in clinical practice.
Global Image Guided Radiotherapy Market, Segmentation by Geography
In this report, the Global Image Guided Radiotherapy Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Image Guided Radiotherapy Market Share (%), by Geographical Region, 2024
The global image-guided radiotherapy (IGRT) market exhibits geographical variations in market share, with different regions contributing differently to the overall market. North America currently holds a significant share of the market, driven by factors such as advanced healthcare infrastructure, high adoption of technologically advanced medical devices, and increasing cancer prevalence. The region is characterized by the presence of key market players, research institutions, and healthcare facilities offering IGRT services, contributing to its dominance in the global market.
Europe follows closely behind North America in terms of market share, with countries like Germany, the UK, and France leading the adoption of IGRT technology. The region benefits from robust healthcare systems, government initiatives supporting cancer care, and a growing emphasis on precision medicine. Additionally, favorable reimbursement policies and increasing awareness among healthcare professionals and patients further contribute to the growth of the IGRT market in Europe.
Asia Pacific represents a region of immense growth potential for the IGRT market, fueled by factors such as the large population base, rising cancer incidence rates, and improving healthcare infrastructure. Countries like China, Japan, and India are witnessing increased investments in cancer care and radiotherapy services, driving the adoption of IGRT technology. Moreover, initiatives aimed at improving access to advanced medical technologies and expanding healthcare coverage are expected to further propel market growth in the Asia Pacific region in the coming years.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Image Guided Radiotherapy Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Cancer Incidence Rates
- Technological Advancements in Imaging Modalities
- Growing Demand for Precise-The global image-guided radiotherapy (IGRT) market is experiencing a surge in demand driven by the growing need for precise and effective cancer treatment options. As cancer incidence rates continue to rise worldwide, healthcare providers are increasingly turning to advanced radiotherapy techniques like IGRT to improve treatment outcomes and minimize radiation-related side effects. IGRT offers unparalleled precision by incorporating real-time imaging technology to accurately target tumors while sparing surrounding healthy tissues, thus maximizing the therapeutic effect while reducing the risk of collateral damage.
The emphasis on personalized medicine and patient-centric care is fueling the demand for precise treatment modalities like IGRT. Patients are increasingly seeking treatment options that not only offer optimal therapeutic outcomes but also minimize treatment-related toxicity and improve quality of life. IGRT's ability to adapt treatment plans based on individual patient anatomy and tumor characteristics aligns with this trend, making it an attractive option for both patients and healthcare providers striving for tailored and effective cancer care.
Advancements in imaging modalities and software technologies are further driving the adoption of IGRT, enabling even greater precision and accuracy in radiation therapy delivery. Integration of advanced imaging techniques such as MRI and PET with IGRT systems enhances tumor visualization and localization, allowing for more refined treatment planning and delivery. Additionally, ongoing research and development efforts aimed at improving IGRT techniques and workflows are expected to expand the scope of applications and further enhance treatment outcomes, positioning IGRT as a cornerstone in modern cancer therapy.
Restraints
- High Initial Investment Costs
- Limited Accessibility in Some Regions
- Need for Specialized Equipment-The global image-guided radiotherapy (IGRT) market faces a significant challenge due to the need for specialized equipment, which can serve as a barrier to widespread adoption. Implementing IGRT requires sophisticated imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), integrated with radiotherapy systems. These imaging technologies not only add to the initial capital investment but also require ongoing maintenance and operational costs. Additionally, the installation and setup of IGRT equipment necessitate specialized expertise, including medical physicists and radiographers trained in radiation oncology, further adding to the complexity and cost of implementation.
The need for specialized equipment can limit the accessibility of IGRT in certain regions, particularly in resource-constrained healthcare settings. Hospitals and clinics in low- and middle-income countries may lack the infrastructure and financial resources required to invest in state-of-the-art IGRT systems. This disparity in access to advanced radiotherapy technologies exacerbates existing inequalities in cancer care, as patients in underserved regions may not have access to the same level of treatment options as those in more developed areas.
Efforts are underway to address the challenges posed by the need for specialized equipment in the IGRT market. Collaborative initiatives between governments, healthcare organizations, and industry stakeholders aim to improve access to advanced radiotherapy technologies in underserved regions through capacity-building programs, technology transfer initiatives, and financial assistance schemes. Additionally, ongoing advancements in technology, including the development of more compact and cost-effective IGRT systems, hold promise for overcoming some of the barriers associated with specialized equipment, ultimately expanding access to high-quality cancer care worldwide.
Opportunities
- Rising Awareness about the Benefits of IGRT
- Ongoing Technological Advancements
- Increasing Investments-Investments in the global image-guided radiotherapy (IGRT) market are playing a pivotal role in driving advancements and expanding accessibility to this cutting-edge cancer treatment technology. With cancer incidence rates continuing to rise globally, there is a growing recognition of the need for innovative and precise treatment options such as IGRT. Consequently, healthcare organizations, research institutions, and governments are increasingly allocating resources towards the development and adoption of IGRT technologies, aiming to improve cancer treatment outcomes and patient survival rates.
These investments are fueling technological advancements in IGRT, leading to the development of more sophisticated imaging modalities, treatment planning software, and radiotherapy systems. Integration of advanced imaging technologies such as MRI, CT, and PET with IGRT systems enables healthcare providers to precisely visualize tumors and surrounding anatomy in real-time, facilitating accurate treatment delivery and minimizing radiation exposure to healthy tissues. Furthermore, investments in research and development are driving innovation in motion management techniques and adaptive treatment strategies, enhancing the effectiveness and safety of IGRT for a wide range of cancer types and patient populations.
Increasing investments in healthcare infrastructure and oncology care are expanding access to IGRT services, particularly in developing regions where cancer treatment resources may be limited. Governments and healthcare authorities are recognizing the importance of investing in radiotherapy facilities equipped with IGRT capabilities to meet the growing demand for cancer treatment services. Additionally, partnerships between healthcare providers, industry stakeholders, and philanthropic organizations are fostering collaborations aimed at improving access to IGRT technology, training healthcare professionals, and raising awareness about its benefits, thereby driving market growth and positively impacting patient outcomes worldwide.
Competitive Landscape Analysis
Key players in Global Image Guided Radiotherapy Market include:
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- Siemens Healthineers AG
- ViewRay, Inc.
- C-RAD AB
- Brainlab AG
- Mevion Medical Systems, Inc.
- IBA Dosimetry GmbH
- Hitachi, Ltd.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Types
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Image Guided Radiotherapy Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Cancer Incidence Rates
- Technological Advancements in Imaging Modalities
- Growing Demand for Precise
- Restraints
- High Initial Investment Costs
- Limited Accessibility in Some Regions
- Need for Specialized Equipment
- Opportunities
- Rising Awareness about the Benefits of IGRT
- Ongoing Technological Advancements
- Increasing Investments
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Image Guided Radiotherapy Market, By Types, 2021 - 2031 (USD Million)
- Soft-Tissue Imaging
- Lung MRI
- Simplifying Cardiac MRI
- Simplifying MRI-Conditional Implant Scans
- Silent MRI Scanning
- Others
- Global Image Guided Radiotherapy Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals
- Smart Cancer Centers
- Research Institutes
- Others
- Global Image Guided Radiotherapy Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Image Guided Radiotherapy Market, By Types, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- Siemens Healthineers AG
- ViewRay, Inc.
- C-RAD AB
- Brainlab AG
- Mevion Medical Systems, Inc.
- IBA Dosimetry GmbH
- Hitachi, Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market